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Abstract
Background The management of congenital diaphragmatic
hernia (CDH) is a major challenge. The mortality is
dependent on associated malformations, the severity of
pulmonary hypoplasia, pulmonary hypertension and iatro-
genic lung injury associated with aggressive mechanical
ventilation. The aims of the study were to investigate the
mortality over time in a single paediatric surgical centre, to
compare the results with recent reports and to define the
risk factors for mortality.
Methods The medical records of infants with CDH from
two time periods: 1995–2005 and 2006–2016 were
reviewed. Cox regression was used for statistical analysis.
Results The study included 113 infants. The mortality rate
was significantly decreased in the later time period, com-
pared to the earlier, 4.4 and 17.9%, respectively. At the
early time period five patients (7.5%) were treated with
ECMO and in the later time period ECMO was used in
three patients (6.5%). The mortality in ECMO-treated
patients was 50% in both time periods. Prenatal diagnosis,
intrathoracic liver, low Apgar score and low birth weight
were defined as independent risk factors for mortality.
Conclusion Despite no significant differences in the
incidence of independent risk factors and the use of
ECMO between the two time periods, mortality decreased
over time. The mortality was lower than previously
reported. The results indicate that there are many
important factors involved in a successful outcome after
CDH repair. Large multicentre studies are necessary to
define those critical factors and to determine optimal
treatment strategies.
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Introduction
The management of congenital diaphragmatic hernia
(CDH) is a major challenge in paediatric surgery. The
incidence of CDH is between 1 in 2500 and 5000 live
births [1–3]. A mortality rate of 10–30% has been
reported but is still higher in patients with severe pul-
monary hypoplasia and pulmonary hypertension [4–8].
Mortality in CDH patients treated with extracorporeal
membrane oxygenation (ECMO) was approximately 50%
in a recent report from ELSO (Extracorporeal Life Sup-
port Organisation) [9]. Prenatal diagnosis, LHR (lung-to-
head-ratio) n\ 1, intrathoracic liver, right-sided CDH,
associated malformations, a large diaphragmatic defect,
low 5-min Apgar score and prematurity are other factors
that have been associated with high mortality
[2, 3, 8, 10–16]. Also the timing of surgery might influ-
ence the mortality rate in high-risk CDH and the practice
of clinical stability before surgery is widely advocated
[10, 17, 18]. The aims of the study were to investigate the
mortality over time in a single paediatric surgical centre,
to compare the results with recent reports and to define
the risk factors for mortality.
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Patients and methods
This is a retrospective observational study of all the infants
with repaired CDH between January 1995 and January
2016 at the University Children’s Hospital, Uppsala,
Sweden. Neonates primarily managed in our centre who
were sent for ECMO to other paediatric surgical centres
were also included. Patients with primary repair in other
centres who later had a repair of recurrent CDH in our
centre and patients not surviving until surgery were
excluded. Patients with diaphragmatic eventration were
excluded. The use of patient data in this study was
approved by the Regional Committee on Medical Research
Ethics (Dnr 2016/140). Data extracted from the medical
records were prenatal diagnosis, LHR, liver in thorax,
gender, gestational age and birth weight, Apgar score,
treatment with ECMO, age at surgery (days), side of the
defect, associated malformations, the size of the defect as
determined by the surgeon at the time of surgery and if a
patch was used. If the patient died, the age at death was
registered. The study period was 900 days after surgery or
until death. A major cardiac anomaly was defined
according to Spitz (congenital heart disease that required
medical or surgical treatment) [19].
Statistical analysis
Descriptive statistics are presented as median and range for
continuous variables and as absolute and relative frequen-
cies for categorical variables. Survival is presented as
Kaplan–Meier curves. All patients that underwent CDH
repair were included in the Kaplan–Meier estimate,
regardless of the length of follow-up time. Possible inde-
pendent risk factors for mortality were analysed in three
steps. In the first step, selected independent factors had
been evaluated using univariate Cox proportional hazards
model presented as Hazard ratio (HR) with 95% confidence
interval (CI). In the second step, variables with a p value
\0.05 in the univariate analysis were entered into a mul-
tivariate analysis. In the third step, the model was subject to
a backward stepwise procedure where the best model was
determined as the model with the smallest Akaike infor-
mation criteria (AIC) value. Estimates where p\ 0.05
were considered significant, but since no adjustment for
multiplicity has been performed the overall type I error rate
may exceed 5%. Thus, the p values should be interpreted in
an exploratory manner rather than as confirmatory. Statis-
tical analyses were performed using R version 3.2.2,
Copyright (C) 2015 The R Foundation for Statistical
Computing.
Results
A total of 113 patients were included, 67 in the early time
period (1995–2005) and 46 in the later time period
(2006–2016) (Table 1). The distribution of males and
females was similar in both time periods. Median gesta-
tional age was 38 weeks in both time periods and birth
weight was 3192 g in the early and 3215 g in the later time
period. Median age at surgery was 2 days in the early and
3 days in the later time period. The incidence of major
cardiac anomaly was 13.4% in the early and 26.1% in the
later time period and the incidence of chromosomal
abnormalities was 3% in the early and 2.2% in the later
time period. The frequencies of other malformations such
as esophageal atresia, gastroschisis, bladder exstrophy,
omphalocele, myelomeningocele, Pentalogy of Cantrell,
Fryns- and Pierre Robin syndrome and renal agenesis were
Table 1 Patient characteristics
in the two different time periods
Patient characteristics 1995–2005 (n = 67) 2006–2016 (n = 46) p value
Boys 34 (50.8%) 26 (56.5%) 0.570
Girls 33 (49.2%) 20 (43.5%)
Prenatal diagnosis 19 (28.4%) 16 (34.8%) 0.536
Intrathoracic liver 15 (22.4%) 6 (13%) 0.231
Median gestational age weeks (range) 38 (24–42) 38 (30–42) 0.238
Median birth weight grams (range) 3192 (706–4341) 3215 (1500–4774) 0.147
Major cardiac defects 9 (13.4%) 12 (26.1%) 0.138
Chromosomal abnormalities 2 (3%) 1 (2.2%) 1.000
Other malformations 10 (14.9%) 5 (10.9%) 0.586
Large defect size 26 (40.6%) 14 (31.8%) 0.284
Right sided 13 (19.4%) 6 (13.0%) 0.449
Median age at surgery days (range) 2 (1–3638) 3 (1–1159) 0.937
ECMO 5 (7.5%) 3 (6.5%) 1.000
Mortality rate 12 (17.9%) 2 (4.4%) 0.041
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14.9% in the early and 10.9% in the later period. Prenatal
diagnosis was found in 28.4% of the patients in the early
and 34.8% in the later time period and the incidence of
intrathoracic liver was 22.4% in the early and 13% in the
later time period.
The LHR measurements started in the period between
2006 and 2016. Data on LHR were missing in 6 out of 16
patients with prenatal diagnosis, and were too few to be
included in the analysis. At the early time period 40.6% of
the patients had a large diaphragmatic defect compared to
31.8% in the later time period (Table 1). Five patients
(7.5%) were treated with ECMO in the early and three
patients (6.5%) in the later time period. The mortality in
those patients was 50%. The mortality rate of 4.4% was
significantly lower in the period between 2006 and 2016
compared to 17.9% in the period from 1995 to 2005 as
demonstrated in Table 1. During the whole study period
from 1995 to 2016, the overall mortality was 12.3% and if
neonates who died before surgery were included, the
mortality rate was 19.5%. In Table 2, neonates who died
prior to surgery or were not candidates for surgical repair
are shown. Patient number 1–8 were born during the early
time period and number 9 and 10 during the later time
period. In patient number 4 and 8, withdrawal of care was
done due to trisomy 18.
Patients died earlier after surgery in the early time
period (Fig. 1). The survival in patients with a small
defect was 100% compared to 72% in patients with a
large diaphragmatic defect as demonstrated in Fig. 2.
Table 3 demonstrates the potential risk factors included in
the univariate Cox proportional hazards model. The risk
to die was 6.89 times higher in patients with a large
diaphragmatic defect. Patients with an intrathoracic liver
had 6.37 times higher risk, infants with a prenatal diag-
nosis 4.32 and ECMO-treated patients had 6.61 times
higher risk to die than patients without those risk factors.
Multivariate analysis confirmed a significant association
with mortality independent of the other variables for
prenatal diagnosis, intrathoracic liver, low Apgar score
and low birth weight as demonstrated in Table 4. For
every 100 g increase in birth weight, the risk to die was
reduced by 7% and for every increase in Apgar score the
risk to die was reduced by 34%. Prenatal diagnosis and
intrathoracic liver increased the risk to die with 4.55 and
4.0 times, respectively.
Discussion
Comparing mortality between different reports is confusing
as mortality rates are reported for heterogenous populations
with CDH from centres with highly varied treatment
strategies and volumes of patients. In the study popula-
tions, there is a great variation in the proportion of pre-
natally diagnosed CDH, follow-up time, whether they
include only live-born neonates, if they include neonates
that die before surgery or only patients that undergo sur-
gery. We have performed this study to be able to compare
our results with international reports. During the study
period of two decades, there have been changes in both
surgical and medical practices. The repair of CDH has
changed from a surgical emergency in the beginning of the
study period to a planned surgery after stabilization. The
first neonate with CDH in our unit that received ECMO
Table 2 Characteristics of neonates who died prior to surgery or were not candidates for surgical repair
Patient 1 2 3 4 5 6 7 8 9 10
Gender M M F F M F M F M M
Prenatal diagnosis Yes Yes No No Yes Yes No No Yes Yes
Gestational age
(weeks)
37 33 35 40 38 35 37 36 33 25
Birth weight (g) 2350 1950 1790 1981 3420 1460 3000 2200 1770 683
Major cardiac defect Yes No No Yes Yes No No Yes No Yes
Chromosomal
abnormalities
No No Yes Trisomy
18









No No Multipleb No
Side of the defect Left Left Right Left Left Left Right Left Bilat Left
Age at death (days) \1 \1 \1 \1 \1 \1 \1 9 \1 \1
a Esophageal atresia, myelomeningocele, renal agenesis
b Omphalocele, myelomeningocele, bladder exstrophy
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was born in the year 2000. High-frequency oscillatory
ventilation and inhaled nitric oxide were increasingly used
therapies during the study period. Treatments of pulmonary
hypertension with sildenafil and bosentan were introduced
during the late time period, 2006–2016.
In the present study, prenatal diagnosis, intrathoracic
liver, low birth weight and low Apgar score were defined
as independent risk factors for mortality. The mortality
rate decreased significantly to 4.4% in the later time
period even though there was no significant difference in
the incidence of the defined risk factors, and it was lower
than previously reported [1–3]. Our findings are in
accordance with previous reports that found low Apgar
score and low birth weight to be strong predictors of
mortality [20–22]. The Congenital Diaphragmatic Hernia
Study Group (CDHSG) previously published a formula
utilizing birth weight and 5-min Apgar score to predict
mortality in patients with CDH [20]. However, these
factors are not specific for CDH and they have long been
associated with adverse outcome in infants with other
congenital malformations [23]. Nevertheless, avoidance of
prematurity and optimizing preoperative management















Fig. 1 Kaplan–Meier estimates
of the cumulative risk of
survival up to 900 days in the















Fig. 2 Kaplan–Meier estimates
of the cumulative risk of
survival up to 900 days in
patients with small, medium and
large diaphragmatic defects
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The intrathoracic liver has been defined as an indepen-
dent risk factor for mortality [24–28]. It is not surprising as
an intrathoracic liver is indicative of a large diaphragmatic
defect with early herniation of viscera resulting in severe
pulmonary hypoplasia.
The frequency of associated malformations in the cur-
rent study was higher in the later time period than in a
meta-analysis of 102 publications from 1975 to 1998 [10].
In contrast to others, associated malformations were not
defined as an independent risk factor in this study
[10, 15, 29, 30].
The incidence of prenatal diagnosis was higher in the
later time period (35%) and in accordance with the pooled
incidence of prenatal diagnosis in a meta-analysis of Skari
et al. [10]. It was lower than in an evaluation from 2002 of
prenatal diagnosis in 20 European regions with an overall
prenatal detection rate of 59% in 187 cases [31]. Prenatal
diagnosis was found to be the strongest predictor of mor-
tality in our series of patients as previously reported
[10, 32]. The likelihood of prenatal detection increases
with large defects with a considerable mediastinal shift and
severe pulmonary hypoplasia [10, 32].
The CDHSG reported the defect size to be the strongest
predictor of survival [4]. Although a large defect size was
associated with higher mortality in the present study it was
not found to be an independent risk factor for mortality.
In contrast to a meta-analysis of 2980 patients with
CDH, there was no difference in mortality between right-
and left-sided CDH in the present study [10].
Permissive hypercapnia and ‘‘gentle ventilation’’ have
been reported to increase survival in neonates with CDH
[33, 34]. A decrease in the ECMO utilization has been
noted in infants managed with permissive hypercapnia
and gentle ventilation strategies [33, 34]. A possible
explanation for the decreased mortality in the later time
period might be that the neonates with CDH were man-
aged in the largest neonatal intensive care unit in the
country with a wide experience in ‘‘gentle ventilation’’ in
extremely premature neonates. Improved medical treat-
ment of pulmonary hypertension in the later time period
might also have contributed to the decreased mortality.
Hagadorn et al. found that improved survival in CDH was
associated with the increasing use of multiple vasodilators
[35].
The benefit of ECMO in the treatment of infants with
CDH remains unclear [36]. The efficacy of ECMO in
reducing mortality has not been convincing in randomized
trials [37, 38]. The incidence of ECMO-treated patients in
the present study was low, 7.5 and 6.5% in the early and
later time period, respectively, and the mortality rate was
50%. It was the same mortality rate as reported by the
ELSO Registry in 2012 [39]. The proportion of neonates
requiring ECMO has declined but the mortality rates for
neonates supported on ECMO have increased [40, 41].
Our paediatric surgical centre is defined as a low-vol-
ume hospital (B6 cases per year) according to a previous
study in 2203 infants with CDH repair [42]. They found
higher mortality rates in low-volume hospitals than in high-
volume hospitals ([10 cases per year), 23 and 16%,
respectively. However, a more recent study in 3738 infants
showed no difference in mortality between low- and high-
volume hospitals [43].
The strengths of this study are the quite large number of
patients and no patients were lost to follow-up. The main
weakness of this study is its retrospective design and it is
being representative of a single centre.
Conclusion
In the present study, mortality decreased over time, despite
no significant difference in the incidence of independent
risk factors and the use of ECMO between the two time
periods. The mortality was lower than previously reported.
The results indicate that there are many important factors
involved to achieve a successful outcome after CDH repair.
Large multicentre studies are necessary to define those
critical factors and to determine optimal treatment
strategies.
Table 3 Cox proportional hazards model: univariate analysis
Variable Coefficient 95% CI p value
Gender 1.57 (0.53–4.70) 0.416
Right-sided CDH 0.93 (0.21–4.17) 0.928
Associated malformations 2.13 (0.74–6.14) 0.161
Age at surgery 0.95 (0.86–1.04) 0.255
Large diaphragmatic defect 6.89 (1.92–24.75) 0.003
Birth weight per 100 g 0.94 (0.88–1.00) 0.034
Gestational age 0.89 (0.78–1.02) 0.088
Prenatal diagnosis 4.32 (1.45–12.91) 0.009
Intrathoracic liver 6.37 (2.00–20.33) 0.002
Apgar 1 min 0.7 (0.55–0.90) 0.004
Apgar 5 min 0.7 (0.55–0.89) 0.004
Apgar 10 min 0.68 (0.52–0.88) 0.003
ECMO 6.61 (2.06–21.13) 0.001
Table 4 Multivariate cox proportional hazards model: stepwise
based on significant variables in univariate analyses
Variable Coefficient 95% CI p value
Birth weight per 100 g 0.93 (0.86–1.01) 0.083
Intrathoracic liver 4.00 (1.15–17.20) 0.03
Apgar score 0.66 (0.47–0.86) 0.003
Prenatal diagnosis 4.55 (1.32–19.75) 0.018
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